Industry News

Jan 09, 2014
By BioPharm International Editors
Eurofins acquires DDS business of Merck KGaA in order to expand discovery solutions and bioanalytical services.
Jan 09, 2014
By BioPharm International Editors
CytomX Therapeutics and ImmunoGen announce collaboration to develop probody-drug conjugate therapies for the treatment of cancer.
Dec 31, 2013
By BioPharm International Editors
Genzyme plans to appeal FDA?s decision that the multiple-sclerosis treatment is not ready for approval.
Dec 30, 2013
By BioPharm International Editors
Baxter International recalls dextrose injection and four sodium chloride injections.
Dec 23, 2013
By BioPharm International Editors
Pall Corporation, a solutions provider in filtration, separation and purification, has signed a definitive agreement with ATMI to acquire ATMI's LifeSciences business unit for $185 million.
Dec 19, 2013
By BioPharm International Editors
ProBioGen signs agreement with Emergent BioSolutions for access to ProBioGen's avian AGE1.CR cell line.
Dec 19, 2013
By BioPharm International Editors
Siemens enters agreement with Pfizer to commercialize diagnostic tests for therapeutic products across Pfizer's pipeline.
Dec 19, 2013
By BioPharm International Editors
Leidos Holdings awards Pfenex a subcontract in support of the development of an anthrax vaccine.
Dec 19, 2013
By BioPharm International Editors
Pfizer appoints management changes to take effect in 2014.
Dec 19, 2013
By BioPharm International Editors
CMC Biologics and OnoSynergy form an agreement from cell-line development.
native1_300x100
lorem ipsum